Irving-based Biote Corporation, a preventive healthcare solutions provider that delivers personalized hormone therapy, has appointed John Denne as general manager of its men’s health division. The move is aimed at expanding the company’s presence in the growing market for male hormone replacement therapy.
Biote, which was founded in 2012, went public on Nasdaq in May 2022 through a SPAC deal....